APHA Annual Meeting 2020
The APHA Annual Meeting and Expo, being held virtually October 24-28, is the largest and most influential yearly gathering of public health professionals. APHA brings together the public health community to experience robust scientific programming, networking, social events, poster sessions and more. Even though the event is being held online this year, the cooperation among organizations, governments, and experts to improve public health outcomes remains the same.
This year’s meeting features a mix of live and on-demand sessions that focus on the 2020 theme, “Creating the Healthiest Nation: Preventing Violence” and will address the COVID-19 pandemic and many other public health topics. Join us to explore how science, action and health can help us create the healthiest nation and see what public health experts are doing to address these areas.
Be sure to visit us at Booth #700 in the virtual Exhibit Hall! Our recruiting team will be available to chat with you live during the following times:
- Monday, October 26: 2:00 PM–3:00 PM EST (12:00 PM–1:00 PM MT)
- Tuesday, October 27: 2:00 PM–3:00 PM EST (12:00 PM–1:00 PM MT)
- Wednesday, October 28: 1:00 PM–2:00 PM EST (11:00 AM–12:00 PM MT)
You can request to set up one-on-one appointments, as well!
To create a healthy nation, RTI continues to pursue cutting-edge research to advance diagnosis and treatment of disease, alleviate health disparities, and improve health well-being across all populations. With a multidisciplinary team of experts and a commitment to innovation, we strive to create a world where people thrive in health and wellness.
Learn more about our work in the following topics:
RTI helps partners build resilient health systems and improve public health. In response to the COVID-19 pandemic, we are working quickly to lessen its impact on the individuals and communities we serve. RTI offers extensive experience addressing public health threats and improving the underlying systems where they occur and the effects they leave in their wake. Our researchers provide new data and insights into COVID-19.
RTI announced that it has been selected to collaborate in an initiative to understand the risk of severe illness from COVID-19 and identify therapies that will slow or halt the disease progression and speed recovery. Referred to as Collaborating Network of Networks for Evaluating COVID-19 and Therapeutic Strategies, or CONNECTS, the initiative is being led by the National Heart, Lung and Blood Institute, part of the National Institutes of Health.
New pandemic data is released daily and a quick search for “COVID-19 data” provides millions of results and countless tools. How do you determine if the data gives you an accurate, comprehensive view of your community? How do you create action plans from the data for your community? The RTI COVID-19 Data Insights Tool gives those in charge of the public health crisis response access to COVID-19 data and the ability to cross-compare it with socio-economic vulnerability factors to deliver hyperlocal insights.
Gun Violence / Injury and Violence Prevention
The consequences of substance use and misuse, mental disorder, and violence can be devastating. The most effective way to promote health and well-being is to support communities in which everyone, regardless of background, has the opportunity for physical and mental health. RTI promotes evidence-based prevention, harm reduction, and treatment strategies to help communities thrive.
RTI International has been granted three awards from the Centers for Disease Control and Prevention (CDC) and a fourth as a subcontractor to the Prevention Institute to bolster violence prevention efforts across four critical areas: suicide, youth violence and adverse childhood experiences (ACEs), firearm violence, and sexual violence.
Health Equity / Social Determinants of Health
In January 2018, a woman in Baltimore was found outside on a freezing cold night wearing nothing but a hospital gown and socks, having been recently discharged from a local hospital. Video of the event made national headlines, prompting an apology from the hospital and an investigation from the Centers for Medicare and Medicaid Services (CMS). CMS’s reports highlighted several deficiencies in the circumstances that led to the woman’s situation. Remedying the deficiencies in the report may prevent another incident of inappropriate discharge, but they would do little to address the underlying causes that led to the woman’s plight, including poverty, mental illness, and housing insecurity.
Racism and Health
As confirmed COVID-19 cases top 1.8 million in the United States and the pandemic batters our nation’s health care system and economy, data are starting to retell an all-too-familiar story: Black Americans are disproportionately affected. Simply put, black Americans’ COVID-19 hospitalization and death rates are too high considering that we only make up about 13 percent of the US population. As health researchers, government officials, and philanthropists sound the alarm and mount a response, they admit that COVID-19 racial health disparities were to be expected.
Each year, more than 28,000 Americans die from opioid overdoses. For more than 30 years we’ve studied the use of illegal drugs, including heroin and the nonmedical use of opioid pain relievers. Our experts are studying prevention and public communication tactics, strategies to reach out to at-risk and vulnerable populations, the scope of the opioid overdose epidemic and its economic impact, and the cost-benefits of various treatment programs. Our experts are also researching cutting-edge treatments for habitual opioid users as well as those dealing with chronic, unmanageable pain.
Researchers at RTI have contributed to a special edition of Drug and Alcohol Dependence that features 10 papers detailing the ambitious HEALing Communities Study, an effort funded by the National Institutes of Health (NIH) to reduce opioid-related overdose deaths by 40% in 67 communities across Kentucky, Massachusetts, New York and Ohio.
RTI recently won a grant from the National Institute on Drug Abuse for a study on polysubstance use to inform opioid overdose prevention efforts. The three-year, mixed-methods study, led by Jennifer Lorvick, DrPH, will help researchers and policymakers better understand the motivations, contexts, and timing of polysubstance use (including alcohol use) among people who use opioids, which will help refine overdose prevention efforts during and after the COVID-19 pandemic.
Reproductive and Sexual Health
A study published in The Lancet found that administering a low-dose aspirin regimen for pregnant women in low- and middle-income countries can reduce pre-term delivery by 11%. The study was led by Matthew K. Hoffman of Christina Care in Newark, Delaware, with RTI International and colleagues in the Global Network for Women’s and Children’s Health Research, a clinical trials network funded by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development.